Table II.
Semi-quantifications of the immunoreactivities of GK and GKRP in the hippocampal CA1 and CA2/3 regions in the ischemia and IPC + ischemia groups.
| Antibody | Region | Group | Category | Time following ischemia-reperfusion
|
|||
|---|---|---|---|---|---|---|---|
| Sham | 1 day | 2 days | 5 days | ||||
| GK | CA1 | Ischemia | CSP | ++ | ++ | + | ± |
| CSOR | + | ± | ± | ± | |||
| IPC+ischemia | CSP | ++ | ++ | ++ | ++ | ||
| CSOR | ± | ± | ± | ± | |||
| CA2/3 | Ischemia | CSP | ++ | ++ | ++ | ++ | |
| CSOR | ± | ± | ± | ± | |||
| IPC+ischemia | CSP | ++ | ++ | ++ | ++ | ||
| CSOR | ± | ± | ± | ± | |||
| GKRP | CA1 | Ischemia | CSP | ++ | ++ | + | ± |
| CSOR | + | + | + | ++ | |||
| IPC+ischemia | CSP | ++ | ++ | ++ | ++ | ||
| CSOR | + | + | + | + | |||
| CA2/3 | Ischemia | CSP | ++ | ++ | ++ | ++ | |
| CSOR | + | + | + | + | |||
| IPC+ischemia | CSP | ++ | ++ | ++ | ++ | ||
| CSOR | + | + | + | + | |||
Immunoreactivity is scaled as −, ±, + or ++, representing no staining, weakly positive staining, moderate staining, or marked staining, respectively. Sham, no ischemia reperfusion; CSP, cells in stratum pyramidale; CSOR, cells in stratum oriens and radiatum; IPC, ischemic preconditioning.